Par Pharmaceutical, Inc.
Quick facts
| Founded | 1978 |
|---|
Marketed products
- ARAVA
- Buspar · Other
- Buspirone HCl · Psychiatry/Neurology
Buspirone acts as a serotonin 5-HT1A receptor agonist to reduce anxiety without the sedation or dependence associated with benzodiazepines. - Flagyl · Other
- Inderal-LA
- Klonopin · Neuroscience
- Monodox · Other
- Oxandrin · Other
- Parnate · Neuroscience
Phase 1 pipeline
- Demadex · Other
- Dostinex · Other
- Klonopin Wafers
- Tramadol APAP
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Par Pharmaceutical, Inc.
What are Par Pharmaceutical, Inc.'s marketed drugs?
Top marketed products include ARAVA, Buspar, Buspirone HCl, Flagyl, Inderal-LA, Klonopin.
When was Par Pharmaceutical, Inc. founded?
Par Pharmaceutical, Inc. was founded in 1978.
Related
- ARAVA
- Buspar · Other
- Buspirone HCl · Psychiatry/Neurology
- Flagyl · Other
- Inderal-LA
- Sector hub: All tracked pharma companies